Old National Bancorp (NASDAQ:ONB) last session’s volume of 0.78 million shares was higher than its average volume of 0.74 million shares. The stock, after opening at $16.65, hit $16.3 through the close by scoring -2.4%.

Old National Bancorp (ONB) Analyst Opinion

Old National Bancorp has a consensus hold rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 4.37% of shares outstanding. The stock sank -8.94% last month and is down -9.56 this year. Wall Street is only getting neutral on the stock, with 1 of analysts who cover ONB having a buy-equivalent rating. Analysts have placed a $18.06 price target on Old National Bancorp, suggesting a 10.8% gain from recent close. It’s currently trading about -13.98% below its 52-week high.

Old National Bancorp Earnings Surprise

Old National Bancorp (ONB) revenue totaled $154.85 million down -0.13% from the previous quarter. The good news is, sales may return to growth this quarter. As per the consensus estimate, the company’s year-on-year revenue growth is expected to be at 16% during the period. Last year, it had about $135.09 million of revenue.

Old National Bancorp (NASDAQ:ONB) Intraday View

This stock (ONB) is ahead of its 52-week low with 44.17%. Its last month’s stock price volatility remained 2.5% which for the week stands at 2.95%. The share price has moved backward from its 20 days moving average, trading at a distance of -4.41% and stays -8.02% away from its 50 days moving average. Over the last five days, shares have faced -3.83% losses and now is up 4.47% since hitting its 200-day moving average of $16.84. Old National Bancorp (ONB) has made its way to a 12-month gain of 34.36%.

Turning to BIOLASE, Inc. (NASDAQ:BIOL), its shares were trading at $1.34 a gain of $0.06, on the trading floor. The stock, after opening at $1.3, touched a high of $1.39 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. BIOLASE, Inc. has 0 buy ratings, 0 holds and 0 sells even after the stock tumbled -32.32% from its high of $1.98 to a $93.48 million market value through last close.

BIOLASE, Inc. EPS Forecast

The earnings of BIOLASE, Inc. (BIOL) will be compared to -$0.08 a year-ago quarter. This quarter analysts say they expect sales to move at $13.23 million — higher from $11.23 million the year before.

BIOLASE, Inc. (NASDAQ:BIOL) Intraday Trading

The counter witnessed a trading volume of 0.17 million shares versus an average volume of 0.16 million shares during last trading session. Its last month’s stock price volatility remained 6.29% which for the week approaches 7.19%. The lowest price the stock reached in the last trading day was $1.3 and compares with the $0.8 52-week low. The stock recovered 67.5% since its low point and has performed -4.29% year-to-date.

Previous articleHot Stocks Among Investors: Huntsman Corporation (HUN), Intellia Therapeutics Inc. (NTLA)
Next articleTechnical Roundup On Two Stocks – Verint Systems Inc. (VRNT), Repros Therapeutics Inc. (RPRX)